US2021130414A1PendingUtilityA1
Treating cancer with viral nucleic acid
Assignee: MAYO FOUND MEDICAL EDUCATION & RESPriority: Feb 20, 2007Filed: Jan 11, 2021Published: May 6, 2021
Est. expiryFeb 20, 2027(~0.6 yrs left)· nominal 20-yr term from priority
A61K 35/768C12N 2770/32332C12N 2840/102C12N 7/00A61P 35/00C07K 14/005Y02A50/30C12N 2770/32311C12N 2770/32611C12N 2770/32632
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating cancer present in a mammal, wherein said method comprises administering, to said mammal, an effective amount of nucleic acid coding for a picornavirus under conditions wherein cancer cells present within said mammal undergo cell lysis as a result of synthesis of picornavirus from said nucleic acid, thereby reducing the number of viable cancer cells present within said mammal.Join the waitlist — get patent alerts
Track US2021130414A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.